Parkinson Disease- Treatment and Information

Parkinson's disease (also known as Parkinson diseasean imperative neurotransmitter and the alterations in
or PD) is actually a degenerative disorder of theits concentration can lead to different medical
central nervous system that often impairs that theproblems.TreatmentTreatment isn't always needed
sufferer's motor skills, speech, and othermuch in the early stages of Parkinson disease â""
functions.Parkinson's disease belongs to a group ofmild tremor, for example, it may be inconvenient and
conditions that called movement disorders. It iscause social embarrassment but otherwise that life
characterized by the muscle rigidity, tremor, a slowingcan go on pretty much as normal by parkinson
of physical movement (bradykinesia) and, but indiseases.But as the disease progresses, it will typically
extreme cases, a loss of physical movementbe treated with drugs. Several different drugs are
(akinesia). The major symptoms are the results ofavailable in market . They all work in much and the
decreased stimulation of the motor cortex by thesame way â"" by boosting the depleted levels of
basal ganglia, generally caused by the insufficientdopamine in to the basal ganglia.The best known of
formation and action of dopamine, which is producedthese is Levodopa and it also called L-dopa. When
that in the dopaminergic neurons of the brain.this drug was introduced in the 1960s it was a great
Secondary symptoms that may include high levelrevolution in the treatment of Parkinson's disease. It
cognitive dysfunction and the subtle languagecrosses with no trouble from the bloodstream into
problems. PD is both chronic and thatthe brain tissue, where it is broken just down to
progressive.Parkinson Disease OverviewParkinsonbecome dopamine. The symptoms of tremor and
disease (PD) is an age-related deterioration of theseverity disappeared overnight.However, L-dopa
certain nerve systems, which affects yourdidn't quite live up to its near the beginning promise.
movement also balance, and muscle control.*The effect of the drug wears off that in patients
Parkinson disease is one of the upmost commonafter three to five years, meaning dosage has to be
movement disorders, affecting 1% of people olderincreasingly increased to get the same therapeutic
than the 60 years. PD is about 1.5 times moreeffect. Side effects â"" frequently abnormal
common that in men than in women, and it soinvoluntary muscle movements called the dyskinesias
becomes more common as you age.* The averageâ"" also become ever more severe, and may even
age of onset is that about 60 years. Onset beforebe worse that than the disease itself.So these days,
age 40 years is rather uncommon, but the verydoctors often hold off just giving L-dopa treatment
recent diagnosis of actor Michael J. Fox shows thatin the early stages of Parkinson's, reserving it for
younger people are also vulnerable.* In PD, brain cellswhen symptoms get somewhat more serious. And
deteriorate (or degenerate) that in an area of thethey often combine L-dopa with other drugs that
brain called the significant nigra. From the substantiavery help maintain dopamine levels, such as carbidopa
nigra, specific nerve cell tracts connect to another(this may be combined with L-dopa in one
part of the brain and its called the corpus striatum,preparation; the trade name is the Sinemet). Other
where the neurotransmitter (a chemical messenger insupplementary drugs that include amantadine,
the brain) called the dopamine is released. Dopamine isbromocriptine and pergolide.